We invite you to participate in a study to assess the safety and effectiveness of a new oral medication, compared to a standard control, for treating and maintaining stable conditions in individuals with Inflammatory Bowel Disease (IBD).
Criteria & Qualifications:
• Must be 18 years of age or older.
• Diagnosis of Crohn’s disease or Ulcerative Colitis.
Compensation:
Contact us for more information
| Patient Population |
|---|
Coming Soon! Ulcerative Colitis causes inflammation and ulcers in the colon, resulting in abdominal discomfort. This study evaluates a new treatment's efficacy and safety for those with moderate to severe conditions. It targets individuals unsatisfied with or affected by current therapies' side effects. Criteria & Qualifications: • Is at least 18 years of age or older. • Diagnosed with Ulcerative Colitis. • Is willing to provide medical records. Compensation: Contact Us For More information
Read more
We're offering a study to test a new treatment for severe Crohn's Disease, especially for those who didn't benefit from common treatments. Participants will be divided into groups; some will receive the actual treatment, others a placebo. Those showing significant improvement in the early phase will continue to the next part of the study. Join us to help advance Crohn's Disease research!
Criteria & Qualifications:
• Is at least 18 years of age or older.
Compensation:
Contact us for more information
Colorectal cancer, originating in the colon or rectum, can be aggressive. Clinical trials study promising new therapies to improve patient prognosis. Criteria & Qualifications: • Is at least 18 years of age or older. • Is willing to provide medical records. Compensation: Contact us for more information
Read more
We invite you to participate in a study evaluating the safety and effectiveness of a new oral treatment compared to a standard control in treating and maintaining healed EE.
Criteria & Qualifications:
• Is at least 18 years of age or older.
• Experience heartburn and/or regurgitation consistent with Erosive Esophagitis (EE).
Compensation: Up to $1700
